UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
September
13, 2017
Lombard Medical, Inc.
(Exact Name of Registrant as Specified in
Its Charter)
Commission
File Number
001-36402
N/A
(Translation of Registrant’s Name into English)
|
Cayman Islands |
3841 |
Not applicable |
|
(State or Other Jurisdiction of Incorporation or Organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
4 Trident Park
Didcot
Oxfordshire OX11 7HJ
United
Kingdom
+44 20 1235 750800
(Address, Including ZIP Code,
and Telephone Number, Including Area Code, of Registrant’s Principal
Executive
Offices)
Lombard Medical, Inc.
4 Trident Park
Didcot
Oxfordshire
OX11 7HJ
United Kingdom
(Name, Address of Agent for Service)
Indicate by
check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F:
Form
20-F ⊠ Form
40-F ⃞
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1):___
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):___
Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release of Lombard Medical, Inc. dated September 13, 2017, announcing that it has completed a restructuring and is implementing a strategic plan to achieve profitability.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Lombard Medical, Inc. |
|||
|
|
|||
|
Date: |
September 13, 2017 |
By: |
/s/ Kurt Lemvigh |
|
Kurt Lemvigh |
|||
|
|
|
Chief Executive Officer |
|
-3-